跳至主要内容
临床试验/NCT04033965
NCT04033965已完成不适用

Tumor Mutational Patterns and Infiltrating Lymphocyte Density in Young and Old Patients With Breast Cancer

Hellenic Cooperative Oncology Group0 个研究点目标入组 345 人开始时间: 1997年9月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
345
主要终点
Assessment of the prevalence of gene mutations in women <=35 years old with early breast cancer.

研究概览

简要总结

Age may pertain to different tumor genotype characteristics which may interfere with treatment efficacy and prognosis. The investigators investigated the distribution and prognostic effect of mutations (mut) and tumor infiltrating lymphocyte (TILs) in young and elderly early breast cancer patients (pts).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • women with early breast cancer <35 years old or >65 years old

排除标准

  • 未提供

结局指标

主要结局

Assessment of the prevalence of gene mutations in women <=35 years old with early breast cancer.

时间窗: Up to 13 years

Assessment of the prevalence of gene mutations in women >65years old with early breast cancer.

时间窗: Up to 13 years

Evaluation of Tumor Infiltrating Lymphocytes (TILs) density using descriptive statistics in women <=35 years old with early breast cancer.

时间窗: Up to 13 years

Evaluation of Tumor Infiltrating Lymphocytes (TILs) density using descriptive statistics in women >65 years old with early breast cancer.

时间窗: Up to 13 years

Evaluation of the prognostic effect of gene mutations and Tumor Infiltrating Lymphocytes with respect to Overall Survival in women <=35 years old with early breast cancer

时间窗: Up to 13 years

Evaluation of the prognostic effect of gene mutations and Tumor Infiltrating Lymphocytes with respect to Overall Survival in women >65 years old with early breast cancer.

时间窗: Up to 13 years

次要结局

未报告次要终点

研究者

发起方
Hellenic Cooperative Oncology Group
申办方类型
Other
责任方
Principal Investigator
主要研究者

Manto Nikolaidi

Medical Oncologist

Hellenic Cooperative Oncology Group

相似试验